Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database

The maximum dosage of methotrexate (MTX) for treatment of rheumatoid arthritis (RA) formally approved in Japan is 8 mg/week. We intended to examine the efficacy and safety of MTX at dosages over 8 mg/week in Japanese rheumatoid arthritis patients using the large Institute of Rheumatology, Rheumatoid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seto, Yohei, Tanaka, Eiichi, Inoue, Eisuke, Nakajima, Ayako, Taniguchi, Atsuo, Momohara, Shigeki, Yamanaka, Hisashi
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Japan 2011
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236829/
https://ncbi.nlm.nih.gov/pubmed/21424533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-011-0445-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge